Cargando…
Why not Intravenous Thrombolysis in Patients with Recurrent Stroke within 3 Months?
Acute ischemic stroke continues to be a very severe disorder that has significant impact on human health. Its treatment options are limited and alteplase remains the only American Food and Drug Administration-approved drug for patients with acute ischemic stroke. Furthermore, intravenous thrombolysi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
JKL International LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963351/ https://www.ncbi.nlm.nih.gov/pubmed/29896419 http://dx.doi.org/10.14336/AD.2017.0406 |